PARALYOC 250 mg, lyophilizate oral 10 oral lyophilisates
Active ingredients: Paracetamol
Commercialized according to BDPM
Lyophilizate10 oral lyophilisatesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PARALYOC 250 mg, lyophilisat oral
- Pharmaceutical form
- lyophilisat
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium de 10 lyophilisat(s)
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Sept 1989
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69323970CIP73312941CIP133400933129415Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PARACÉTAMOLlyophilisat | 250 mg · un lyophilisat | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.